Categories: Events

Seminar on baby skincare by global expert

New Delhi, August 09, 2018: Global baby skincare expert Dr. David Mays, Senior Director, Global Scientific Engagement at Johnson & Johnson Consumer, inc was part of the advisory board and addressed healthcare professionals in Mumbai. An expert with over 25 years of experience in the medical and professional education field with a focus on baby and compromised skin, Dr.Mays has been making science transparent for consumers and health care professionals. The discussion mainly focused on the science of baby skin care and its essentials. He spoke about the delicate nature of baby’s skin and how it is affected with various formulations and the environment. The evolution of international baby care standards, the role of research and evolution of ingredients as per the feedback of parents and healthcare professional.

A discussion on Sharing Clinical practices in Baby Skincare also highlighted the best practices in global baby care and addressed the queries from healthcare professionals.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago